AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

IMMURON LTD

0.067

0.000

Volume:- -

Turnover:- -

Market Cap:15.67M

PE:-2.08

High:0.067

Open:0.067

Low:0.067

Close:0.067

Loading ...

Overview Company News Filings

Company Profile

Company Name:

IMMURON LTD

Exchange:

ASX

Establishment Date:

1994

Employees:

7

Office Location:

62 Lygon Street,Level 3,Carlton South,Carlton,Victoria,Australia

Website:

http://www.immuron.com.au

Zip Code:

3053

Phone:

Fax:

61 3 9822 7735

Introduction:

Immuron Limited, a biopharmaceutical company, researches and develops oral immunotherapy polyclonal antibodies for the treatment and prevention of infectious and immune modulated diseases in Australia, the United States, and internationally. The company operates through Research and Development, and HyperImmune Products segments. The company markets Travelan for the prevention of travellers' diarrhea. Its lead product candidates include IMM-124E that is in Phase II clinical trials for non-alcoholic steatohepatitis, severe alcoholic hepatitis, and non-alcoholic fatty liver disease; and IMM-529, a clinical stage product for clostridium difficile infections. The company has a research collaboration with the United States Department of Defense to develop and clinically evaluate a therapeutic against campylobacter. Immuron Limited was founded in 1994 and is based in Carlton South, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/IMC.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMC.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMC.AU\",,,,,undefined,":{"symbol":"IMC.AU","market":"AU","secType":"STK","nameCN":"IMMURON LTD","latestPrice":0.067,"timestamp":1749103920000,"preClose":0.067,"halted":0,"volume":0,"delay":0,"nameEN":"IMMURON LTD","floatShares":200814792,"shares":233842333,"eps":-0.032226,"marketStatus":"Not Yet Opened","change":0,"latestTime":"06-05 16:12:00 AEST","open":0.067,"high":0.067,"low":0.067,"amount":0,"amplitude":0,"askPrice":0.071,"askSize":100000,"bidPrice":0.068,"bidSize":50000,"shortable":3,"etf":0,"ttmEps":-0.032226,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1749168000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.067,"openAndCloseTimeList":[[1749081600000,1749103200000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMC.AU\",,,,,undefined,":{"symbol":"IMC.AU","floatShares":200814792,"roa":"-22.36%","roe":"-52.77%","lyrEps":-0.030443,"shares":233842333,"dividePrice":0,"high":0.067,"amplitude":0,"preClose":0.067,"low":0.067,"week52Low":0.054,"pbRate":"1.52","psRate":"2.40","week52High":0.11,"institutionHeld":0,"latestPrice":0.067,"committee":-0.333333,"eps":-0.032226,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.032226,"open":0.067,"prevYearClose":0.079,"prevWeekClose":0.067,"prevMonthClose":0.067,"prevQuarterClose":0.067,"fiveDayClose":0.072,"twentyDayClose":0.067,"sixtyDayClose":0.08},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":7687411,"yearFounded":1994,"employeeNum":7,"address":"62 Lygon Street,Level 3,Carlton South,Carlton,Victoria,Australia","zipCode":"3053","officePhone":"61 3 9824 5254","officeFax":"61 3 9822 7735"},"stockCompanyDetail":{"websiteUrl":"http://www.immuron.com.au","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.0152},{"period":"3month","weight":-0.141},{"period":"6month","weight":-0.1625},{"period":"1year","weight":-0.2556},{"period":"ytd","weight":-0.1519}],"compareEarnings":[{"period":"1week","weight":0.0014},{"period":"1month","weight":0.052},{"period":"3month","weight":0.0466},{"period":"6month","weight":0.1405},{"period":"1year","weight":0.2068},{"period":"ytd","weight":0.1515}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Immuron Limited, a biopharmaceutical company, researches and develops oral immunotherapy polyclonal antibodies for the treatment and prevention of infectious and immune modulated diseases in Australia, the United States, and internationally. The company operates through Research and Development, and HyperImmune Products segments. The company markets Travelan for the prevention of travellers' diarrhea. Its lead product candidates include IMM-124E that is in Phase II clinical trials for non-alcoholic steatohepatitis, severe alcoholic hepatitis, and non-alcoholic fatty liver disease; and IMM-529, a clinical stage product for clostridium difficile infections. The company has a research collaboration with the United States Department of Defense to develop and clinically evaluate a therapeutic against campylobacter. Immuron Limited was founded in 1994 and is based in Carlton South, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.307692,"avgChangeRate":-0.029536},{"month":2,"riseRate":0.346154,"avgChangeRate":-0.008769},{"month":3,"riseRate":0.230769,"avgChangeRate":-0.065271},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.038875},{"month":5,"riseRate":0.269231,"avgChangeRate":0.040056},{"month":6,"riseRate":0.68,"avgChangeRate":0.140272},{"month":7,"riseRate":0.4,"avgChangeRate":0.061867},{"month":8,"riseRate":0.307692,"avgChangeRate":-0.040212},{"month":9,"riseRate":0.384615,"avgChangeRate":0.018519},{"month":10,"riseRate":0.576923,"avgChangeRate":0.033895},{"month":11,"riseRate":0.307692,"avgChangeRate":-0.055758},{"month":12,"riseRate":0.461538,"avgChangeRate":0.041758}],"exchange":"ASX","name":"IMMURON LTD","nameEN":"IMMURON LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"IMC.AU\",market:\"AU\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMC.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2023-02-28","symbol":"IMC.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1677502800000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMC.AU\",market:\"AU\",,,undefined,":[]}}